Articles

Newer, cheaper and more personalized tests means more people tested and more lives saved.

Road Map to Reducing Colorectal Cancer Deaths

New findings may lead to novel immunotherapies against third-deadliest cancer.


Reprogramming Pancreatic Cancer

Videos

Timothy M. Kuzel, MD, FACP, discusses the use of immunotherapy as a targeted approach to treating cancer.

Dr. Kuzel on Immunotherapy as a Targeted Approach to Cancer

Ruta Rao, MD, associate professor of medical oncology, Rush University Medical Center, discusses the use of abemaciclib with or without fulvestrant for the treatment of hormone receptor–positive and HER2-negative metastatic breast cancer following prior treatment with palbociclib.

Dr. Rao on Abemaciclib Post-Palbociclib in Metastatic Breast Cancer

Shikha Jain, MD, hematologist/oncologist, Rush University Medical Center, discusses the disparities between male and female professionals at medical conferences, specifically the American Society of Clinical Oncology (ASCO) Annual Meeting.

Dr. Jain on Results of Gender Disparities Study in Oncology

Mary J. Fidler, MD, associate professor, Rush University Medical Center, discusses progression-free survival (PFS) and overall survival (OS) in patients with stage IV, nonsquamous, non–small cell lung cancer patients (NSCLC) treated with first-line pemetrexed and platinum followed by pemetrexed maintenance.

Rush

Latest from Rush

New content coming soon, please check back later.